APG Asset Management Trims AbbVie Holdings

Institutional investor reduces stake in pharmaceutical company by 18.5%

Mar. 3, 2026 at 1:39am

Got story updates? Submit your updates here. ›

APG Asset Management N.V., an institutional investor, has trimmed its holdings in AbbVie Inc. (NYSE:ABBV) by 18.5% during the third quarter, according to a recent filing with the Securities & Exchange Commission. The firm now owns 1,220,137 shares of the pharmaceutical company's stock, down from 1,497,023 shares previously.

Why it matters

This reduction in AbbVie holdings by a major institutional investor could signal a shift in sentiment around the stock, which has seen strong performance in recent years. Institutional investors like APG Asset Management play a significant role in shaping the market's perception of a company.

The details

According to the SEC filing, APG Asset Management sold 276,886 shares of AbbVie stock during the third quarter. The firm now owns approximately 0.07% of AbbVie's outstanding shares, valued at $282.5 million as of the most recent reporting period.

  • APG Asset Management filed the disclosure with the SEC on March 1, 2026.
  • The reduction in AbbVie holdings occurred during the third quarter of the previous year.

The players

APG Asset Management N.V.

A major institutional investor that manages assets on behalf of pension funds and other clients.

AbbVie Inc.

A global biopharmaceutical company that develops and commercializes therapies for complex and chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

This reduction in AbbVie holdings by a prominent institutional investor bears watching, as it could signal a broader shift in sentiment around the stock. Investors will likely be closely monitoring AbbVie's performance and any further changes in institutional ownership in the coming quarters.